Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dapsone in the management of autoimmune bullous diseases.

Literature DB >> 22560144

Dapsone in the management of autoimmune bullous diseases.

Abstract

Dapsone is used in the treatment of autoimmune bullous diseases (AIBD), a group of disorders resulting from autoimmunity directed against basement membrane and/or intercellular adhesion molecules on cutaneous and mucosal surfaces. This review summarizes the limited published data evaluating dapsone as a therapy for AIBD.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22560144 PMCID： PMC3928009 DOI： 10.1016/j.iac.2012.04.011

Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN： 0889-8561 Impact factor: 3.479

41 in total

1. Dermatitis herpetiformis: pearls and pitfalls in diagnosis and management.

Authors: Jacqueline M Junkins-Hopkins
Journal: J Am Acad Dermatol Date: 2010-09 Impact factor: 11.527

Review 2. Epidermolysis bullosa acquisita: what's new?

Authors: Norito Ishii; Takahiro Hamada; Teruki Dainichi; Tadashi Karashima; Takekuni Nakama; Shinichiro Yasumoto; Detlef Zillikens; Takashi Hashimoto
Journal: J Dermatol Date: 2010-03 Impact factor: 4.005

Review 3. Cutaneous lupus erythematosus: issues in diagnosis and treatment.

Authors: Hobart W Walling; Richard D Sontheimer
Journal: Am J Clin Dermatol Date: 2009 Impact factor: 7.403

4. Arciform blistering in an elderly woman. Linear IgA dermatosis (LAD).

Authors: S A Long; Z B Argenyi; W W Piette
Journal: Arch Dermatol Date: 1988-11

5. Epidermolysis bullosa acquisita responsive to dapsone therapy.

Authors: A P Hughes; J P Callen
Journal: J Cutan Med Surg Date: 2001 Sep-Oct Impact factor: 2.092

6. Cicatricial pemphigoid.

Authors: C S Foster
Journal: Trans Am Ophthalmol Soc Date: 1986

Review 7. Autoimmune bullous dermatoses: a review.

Authors: Patrícia Patrício; Carlos Ferreira; Manuel Marques Gomes; Paulo Filipe
Journal: Ann N Y Acad Sci Date: 2009-09 Impact factor: 5.691

8. Bullous eruption in a woman with lupus erythematosus. Bullous systemic lupus erythematosus (SLE)

Authors: J H Prystowsky; L Finkel; L Tar; B Jegasothy
Journal: Arch Dermatol Date: 1988-04

Review 9. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.

Authors: Hakan M Gürcan; A Razzaque Ahmed
Journal: Am J Clin Dermatol Date: 2009 Impact factor: 7.403

10. Epidermolysis bullosa acquisita--successful treatment with colchicine.

Authors: M Megahed; K Scharffetter-Kochanek
Journal: Arch Dermatol Res Date: 1994 Impact factor: 3.017

2 in total

1. Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.

Authors: R E Kast
Journal: Springerplus Date: 2015-10-23

2. Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.

Authors: Kim Heang Ly; François Dalmay; Guillaume Gondran; Sylvain Palat; Holy Bezanahary; Anne Cypierre; Anne-Laure Fauchais; Eric Liozon
Journal: Medicine (Baltimore) Date: 2016-10 Impact factor: 1.889

2 in total